Source: Eur Respir J, 50 (6) 1702191; 10.1183/13993003.02191-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vanessa M. McDonald, Janelle Yorke. Adherence in severe asthma: time to get it right. Eur Respir J, 50 (6) 1702191; 10.1183/13993003.02191-2017

Member's Comments

No comment yet.

Related content which might interest you: Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Patient-reported versus objective adherence and exacerbation rates in severe asthma. Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Time to move away from peak flows in severe asthma? A symptom based score that predicts exacerbations. Source: International Congress 2017 – Monitoring asthma control Year: 2017 Right ventricular function in severe asthmatic children: the connection with asthma control level Source: Eur Respir J 2007; 30: Suppl. 51, 760s Year: 2007 Noneosinophilic asthma: persistence over time and effect of treatment Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Time to exacerbation in the ²real-life² management of asthma (GPRD-REALITY) Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008 Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Asthma symptoms, SABA use, and lung function before and after a moderate or severe exacerbation Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Severe asthma: classification and treatment Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019 Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Heterogeneity and time course of asthma exacerbations: data from AUSTRI Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Agreement between patient-reported and chart documented outcomes: Case study in COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015